MedTrace Logo

Cross-Sectional Study of COPD Prevalence Among Smokers, Ex-smokers and Never-Smokers in Almaty, Kazakhstan

NCT02926534 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 900

Last updated 2017-10-30

No results posted yet for this study

Summary

The purpose of this study is to assess the prevalence of COPD among individuals aged 35 - 59 years based results of spirometry before and after bronchodilator, presence of structural changes in lungs (emphysema, inflammatory changes and thickening of the walls of the large and small airways)detected by computer tomography as well as the symptoms of COPD. The study has three study groups: smokers of conventional cigarettes; those who had quit smoking 1 - 5 years ago, and those who haven't smoked cigarettes.

Conditions

  • Chronic Obstructive Pulmonary Disease (COPD)

Sponsors & Collaborators

  • Philip Morris International

    collaborator INDUSTRY

  • Synergy Research Group

    collaborator INDUSTRY

  • HealthCity LLP

    collaborator UNKNOWN

  • Kazakhstan Academy of Preventive Medicine

    lead OTHER

Principal Investigators

  • Almaz T Sharman, MD, PhD · Kazakhstan Academy of Preventive Medicine

Eligibility

Min Age
35 Years
Max Age
59 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2017-05-31
Completion
2017-05-31

Countries

  • Kazakhstan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02926534 on ClinicalTrials.gov